152 related articles for article (PubMed ID: 17369827)
1. Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster.
Tong JJ; Schriner SE; McCleary D; Day BJ; Wallace DC
Nat Genet; 2007 Apr; 39(4):476-85. PubMed ID: 17369827
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
[TBL] [Abstract][Full Text] [Related]
3. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
[TBL] [Abstract][Full Text] [Related]
4. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.
Hannan F; Ho I; Tong JJ; Zhu Y; Nurnberg P; Zhong Y
Hum Mol Genet; 2006 Apr; 15(7):1087-98. PubMed ID: 16513807
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.
Bessler WK; Hudson FZ; Zhang H; Harris V; Wang Y; Mund JA; Downing B; Ingram DA; Case J; Fulton DJ; Stansfield BK
Free Radic Biol Med; 2016 Aug; 97():212-222. PubMed ID: 27266634
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease.
Casani S; Gómez-Pastor R; Matallana E; Paricio N
Free Radic Biol Med; 2013 Aug; 61():151-60. PubMed ID: 23548634
[TBL] [Abstract][Full Text] [Related]
7. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila.
Runko AP; Griswold AJ; Min KT
FEBS Lett; 2008 Mar; 582(5):715-9. PubMed ID: 18258192
[TBL] [Abstract][Full Text] [Related]
9. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the small mitochondrial Hsp22 extends Drosophila life span and increases resistance to oxidative stress.
Morrow G; Samson M; Michaud S; Tanguay RM
FASEB J; 2004 Mar; 18(3):598-9. PubMed ID: 14734639
[TBL] [Abstract][Full Text] [Related]
11. Nmdmc overexpression extends Drosophila lifespan and reduces levels of mitochondrial reactive oxygen species.
Yu S; Jang Y; Paik D; Lee E; Park JJ
Biochem Biophys Res Commun; 2015 Oct; 465(4):845-50. PubMed ID: 26319556
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
13. Drosophila melanogaster neurofibromatosis-1: ROS, not Ras?
Walker JA; Bernards A
Nat Genet; 2007 Apr; 39(4):443-5. PubMed ID: 17392804
[No Abstract] [Full Text] [Related]
14. Over-expression of human clusterin increases stress resistance and extends lifespan in Drosophila melanogaster.
Lee YN; Shim YJ; Kang BH; Park JJ; Min BH
Biochem Biophys Res Commun; 2012 Apr; 420(4):851-6. PubMed ID: 22465014
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation for life span, resistance to paraquat, and spontaneous activity in unselected populations of Drosophila melanogaster: implications for transgenic rescue of life span.
Khazaeli AA; Nuzhdin SV; Curtsinger JW
Mech Ageing Dev; 2007 Sep; 128(9):486-93. PubMed ID: 17688911
[TBL] [Abstract][Full Text] [Related]
16. Extension of Drosophila life span by RNAi of the mitochondrial respiratory chain.
Copeland JM; Cho J; Lo T; Hur JH; Bahadorani S; Arabyan T; Rabie J; Soh J; Walker DW
Curr Biol; 2009 Oct; 19(19):1591-8. PubMed ID: 19747824
[TBL] [Abstract][Full Text] [Related]
17. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1).
Schindeler A; Little DG
Bone; 2008 Apr; 42(4):616-22. PubMed ID: 18248783
[TBL] [Abstract][Full Text] [Related]
19. Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression.
Bonawitz ND; Chatenay-Lapointe M; Pan Y; Shadel GS
Cell Metab; 2007 Apr; 5(4):265-77. PubMed ID: 17403371
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.
Gutmann DH; Tennekoon GI; Cole JL; Collins FS; Rutkowski JL
J Neurosci Res; 1993 Oct; 36(2):216-23. PubMed ID: 7505343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
